Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Antibody, R&D Systems™

Human Monoclonal Antibody

Product Code	Brand	Quantity
18760359	R&D Systems MAB9576-SP	25 μg
18795269	R&D Systems MAB9576-100	100 μg

Description

CD30/TNFRSF8 Monoclonal specifically detects CD30/TNFRSF8 in Human samples. It is validated for Flow Cytometry, CyTOF-ready.

Specifications

• Antigen: CD30/TNFRSF8
• Dilution: Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready
• Classification: Monoclonal
• Form: Supernatant
• Target Species: Human
• Gene Alias: CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8
• Immunogen: Human CD30/TNFRSF8
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
• Test Specificity: Detects human CD30/TNFRSF8 in direct ELISAs. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Brentuximab. This product is for research use only.

• Clone: Hu8
• Applications: Flow Cytometry, CyTOF
• Conjugate: Unconjugated
• Host Species: Human
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 943
• Isotype: IgG1
• Purification Method: Protein A or G purified from cell culture supernatant
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.